HA
IGMS

HHLR Advisors’s IGM Biosciences IGMS Stock Holding History

HHLR Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-151,390
Closed -$12.6M – 96
2021
Q2 		$12.6M Hold
151,390
– – 0.13% 63
2021
Q1 		$11.6M Hold
151,390
– – 0.11% 61
2020
Q4 		$13.4M Sell
151,390
-198,610
-57% -$14M 0.11% 65
2020
Q3 		$25.8M Hold
350,000
– – 0.2% 41
2020
Q2 		$25.6M Hold
350,000
– – 0.23% 40
2020
Q1 		$19.7M Hold
350,000
– – 0.26% 36
2019
Q4 		$13.4M Hold
350,000
– – 0.17% 40
2019
Q3 		$6.21M Buy
+350,000
New +$7.06M 0.09% 53

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors's IGMS Position: Q3 2021 in Review

HHLR Advisors sold out of IGM Biosciences (IGMS) in Q3 2021, closing a stake of 151,390 shares — an estimated $12.6M sold.

HHLR Advisors first reported a position in IGMS in Q3 2019 and held it in 8 quarters. The position peaked at $25.8M in Q3 2020. 107 funds tracked by Wall St. Rank hold IGMS as of Q3 2021.

  • HHLR Advisors reported no remaining IGM Biosciences position as of Q3 2021 after selling out during the quarter.
  • HHLR Advisors sold 151,390 IGM Biosciences shares in Q3 2021, an estimated $12.6M.
  • HHLR Advisors first reported a position in IGM Biosciences in Q3 2019 and held it in 8 quarters.
  • HHLR Advisors's IGM Biosciences position peaked at $25.8M in Q3 2020.
  • 107 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2021.

Based on HHLR Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.